Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2014

01-01-2014 | Review Article

Efficacy of Metabolic Surgery on HbA1c Decrease in Type 2 Diabetes Mellitus Patients with BMI <35 kg/m2—a Review

Authors: Kee Yuan Ngiam, Wei-Jei Lee, Yi-Chih Lee, Anton Cheng

Published in: Obesity Surgery | Issue 1/2014

Login to get access

Abstract

High glycated hemoglobin A1c (HbA1c) is strongly correlated with developing type 2 diabetes mellitus (T2DM) complications; this study reviews the efficacy of various types of metabolic surgeries in reducing HbA1c levels in type 2 diabetics with BMI <35 kg/m2. An electronic search of MEDLINE databases using terms ‘metabolic surgery’, type 2 diabetes mellitus, BMI <35 kg/m2, and related keywords for studies published between 1987 and 2013. Data from 53 articles with 2,258 patients were selected for this review. The weighted mean change in HbA1c was −2.8 % (95 % CI −2.8 to −2.7, p < 0.01) and weighted mean BMI change was −5.5 kg/m2 (95 % CI −5.6 to −5.4, p < 0.01). There was a strong correlation between weighted percentage mean change in HbA1c and BMI. Adjustable gastric banding and duodenal jejunal bypass were inferior to other surgeries in reducing BMI and HbA1c in BMI <35 kg/m2. Metabolic surgery significantly decreases HbA1c in T2DM patients with BMI <35 kg/m2 and that the magnitude of HbA1c change may be a useful surrogate of DM control.
Appendix
Available only for authorised users
Literature
1.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–7. Epub 2001/12/14.PubMedCrossRef
2.
Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–40. Epub 2009/05/28.PubMedCrossRef
3.
Best JH, Lavillotti K, DeYoung MB, et al. The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review. Diabetes Obes Metab. 2012;14(5):387–98. Epub 2011/11/15.PubMedCrossRef
4.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37. Epub 2004/10/14.PubMedCrossRef
5.
Hamet P. What matters in ADVANCE and ADVANCE-ON. Diabetes Obes Metab. 2012;14 Suppl 1:20–9. Epub 2011/12/14.PubMedCrossRef
6.
Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies. Obes Surg. 2010;20(6):776–90. Epub 2010/03/25.PubMedCrossRef
7.
Reis CE, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365–72. Epub 2011/12/20.PubMedCrossRef
8.
Shimizu H, Timratana P, Schauer PR, et al. Review of metabolic surgery for type 2 diabetes in patients with a BMI<35 kg/m(2). J Obes. 2012;2012:147256. Epub 2012/06/22.PubMedCentralPubMedCrossRef
9.
Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2. Diabetes Obes Metab. 2012;14(3):262–70. Epub 2011/11/05.PubMedCrossRef
10.
Diagnosis and classification of diabetes mellitus. Diabetes care. 2010;33 Suppl 1:S62-9. Epub 2010/01/29.
11.
Pournaras DJ, Aasheim ET, Sovik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012;99(1):100–3. Epub 2011/10/25.PubMedCrossRef
12.
DePaula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc. 2008;22(12):2670–8. Epub 2008/03/19.PubMedCrossRef
13.
Kim JW, Cheong JH, Hyung WJ, et al. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenter: WJG. 2012;18(1):49–54. Epub 2012/01/10.CrossRef
14.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. Epub 2012/03/28.PubMedCentralPubMedCrossRef
15.
DePaula AL, Stival A, Halpern A, et al. Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients. World J Surg. 2011;35(1):102–8. Epub 2010/11/06.PubMedCrossRef
16.
DePaula AL, Stival AR, DePaula CC, et al. Surgical treatment of type 2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg: Off J Soc Surg Aliment Tract. 2012;16(5):967–76. Epub 2012/02/22.CrossRef
17.
Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008;31 Suppl 2:S290–6. Epub 2008/02/15.PubMedCrossRef
18.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85. Epub 2012/03/28.PubMedCrossRef
19.
Dixon JB, Hur KY, Lee WJ, Kim MJ, Chong K, Chen SC, et al. Gastric bypass in type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes. Diabetic medicine: a journal of the British Diabetic Association. 2012. Epub 2013/01/03.
20.
Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998;316(7134):823–8. Epub 1998/04/29.PubMedCrossRef
21.
Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800–11. Epub 2010/03/05.PubMedCentralPubMedCrossRef
22.
Turnbull FM, Abraira C, Anderson RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52(11):2288–98. Epub 2009/08/06.PubMedCrossRef
23.
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12. Epub 2000/08/11.PubMedCrossRef
24.
Shah S, Shah P, Todkar J, et al. Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2010;6(2):152–7. Epub 2010/03/02.CrossRef
25.
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8. Epub 2011/02/23.PubMedCrossRef
26.
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23. Epub 2008/01/24.PubMedCrossRef
27.
O’Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33. Epub 2006/05/04.PubMedCrossRef
28.
De Paula AL, Stival AR, Macedo A, et al. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21–34 kg/m(2). Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2010;6(3):296–304. Epub 2010/01/26.CrossRef
29.
Scopinaro N, Papadia F, Marinari G, et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. Obes Surg. 2007;17(2):185–92. Epub 2007/05/05.PubMedCrossRef
30.
Cohen R, Caravatto PP, Correa JL, et al. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2012;8(4):375–80. Epub 2012/03/14.CrossRef
31.
Lakdawala M, Shaikh S, Bandukwala S, Remedios C, Shah M, Bhasker AG. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30–35 kg/m(2)) Indian patients with type 2 diabetes mellitus. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2012. Epub 2012/10/17.
32.
Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg: Off J Soc Surg Aliment Tract. 2008;12(5):945–52. Epub 2007/10/18.CrossRef
33.
Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul-Ghani M, Abood B, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes care. 2013. Epub 2013/02/27.
34.
Angrisani L, Favretti F, Furbetta F, et al. Italian Group for Lap-Band System: results of multicenter study on patients with BMI < or =35 kg/m2. Obes Surg. 2004;14(3):415–8. Epub 2004/04/10.PubMedCrossRef
35.
Choi J, Digiorgi M, Milone L, et al. Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2010;6(4):367–71. Epub 2010/02/27.CrossRef
36.
Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg. 2010;252(3):559–66. discussion 66–7. Epub 2010/08/27.PubMed
37.
Gianos M, Abdemur A, Fendrich I, et al. Outcomes of bariatric surgery in patients with body mass index <35 kg/m2. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2012;8(1):25–30. Epub 2011/10/25.CrossRef
38.
Lee WJ, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg: Off J Soc Surg Aliment Tract. 2012;16(1):45–51. discussion −2. Epub 2011/11/02.CrossRef
39.
Parikh M, Duncombe J, Fielding GA. Laparoscopic adjustable gastric banding for patients with body mass index of < or = 35 kg/m2. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2006;2(5):518–22. Epub 2006/10/04.CrossRef
40.
Sultan S, Parikh M, Youn H, et al. Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2. Surg Endosc. 2009;23(7):1569–73.PubMedCrossRef
41.
Varela JE, Frey W. Perioperative outcomes of laparoscopic adjustable gastric banding in mildly obese (BMI<35 kg/m2) compared to severely obese. Obes Surg. 2011;21(4):421–5. Epub 2011/02/11.PubMedCrossRef
42.
Cohen RV, Schiavon CA, Pinheiro JS, et al. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of 2 cases. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2007;3(2):195–7. Epub 2007/03/28.CrossRef
43.
Ferzli GS, Dominique E, Ciaglia M, et al. Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg. 2009;33(5):972–9. Epub 2009/03/17.PubMedCrossRef
44.
Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg. 2009;19(8):1077–83. Epub 2009/05/29.PubMedCrossRef
45.
Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity (Silver Spring). 2012;20(6):1266–72. Epub 2012/01/21.CrossRef
46.
Lee HC, Kim MK, Kwon HS, et al. Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes Surg. 2010;20(11):1530–5. Epub 2010/08/31.PubMedCrossRef
47.
Ramos AC, Galvao Neto MP, de Souza YM, et al. Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI). Obes Surg. 2009;19(3):307–12. Epub 2008/11/07.PubMedCrossRef
48.
Abbatini F, Capoccia D, Casella G, et al. Type 2 diabetes in obese patients with body mass index of 30–35 kg/m2: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2012;8(1):20–4. Epub 2011/09/20.CrossRef
49.
Kakoulidis TP, Karringer A, Gloaguen T, et al. Initial results with sleeve gastrectomy for patients with class I obesity (BMI 30–35 kg/m2). Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2009;5(4):425–8. Epub 2008/11/11.CrossRef
50.
Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147(5):664–9. Epub 2009/12/17.PubMedCrossRef
51.
Noun R, Chakhtoura G, Nasr M, et al. Laparoscopic sleeve gastrectomy for mildly obese patients (body mass index of 30 <35 kg/m(2)): operative outcome and short-term results. J Obes. 2012;2012:813650. Epub 2013/01/11.PubMedCentralPubMedCrossRef
52.
Frenken M, Cho EY. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB. Obes Facts. 2011;4 Suppl 1:13–7. Epub 2011/11/02.PubMedCrossRef
53.
Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19(10):1341–5. Epub 2009/07/25.PubMedCrossRef
54.
Raj PP, Kumaravel R, Chandramaliteeswaran C, et al. Laparoscopic duodenojejunal bypass with sleeve gastrectomy: preliminary results of a prospective series from India. Surg Endosc. 2012;26(3):688–92. Epub 2011/10/14.PubMedCrossRef
55.
Goel R, Amin P, Goel M, et al. Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients. Int J Diabetes Dev Ctries. 2011;31(2):91–6.CrossRef
56.
Kota SK, Ugale S, Gupta N, et al. Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus. Indian J Endocrinol Metab. 2012;16(4):589–98. Epub 2012/07/28.PubMedCentralPubMedCrossRef
57.
Kumar KV, Ugale S, Gupta N, et al. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther. 2009;11(12):785–9. Epub 2009/12/17.PubMedCrossRef
58.
Tinoco A, El-Kadre L, Aquiar L, et al. Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg. 2011;35(10):2238–44. Epub 2011/07/12.PubMedCrossRef
59.
Alamo M, Sepulveda M, Gellona J, et al. Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index <35 kg/m2. A cohort study. Obes Surg. 2012;22(7):1097–103. Epub 2012/04/25.PubMedCrossRef
60.
Boza C, Munoz R, Salinas J, et al. Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg. 2011;21(9):1330–6. Epub 2011/07/12.PubMedCrossRef
61.
Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8. Epub 2012/06/23.PubMedCrossRef
62.
Cohen R, Pinheiro JS, Correa JL, et al. Laparoscopic Roux-en-Y gastric bypass for BMI<35 kg/m(2): a tailored approach. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2006;2(3):401–4. discussion 4. Epub 2006/08/24.CrossRef
63.
de Sa VC, Ferraz AA, Campos JM, et al. Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2. Obes Surg. 2011;21(3):283–7. Epub 2010/12/15.PubMedCrossRef
64.
Huang CK, Shabbir A, Lo CH, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25–35. Obes Surg. 2011;21(9):1344–9. Epub 2011/04/12.PubMedCentralPubMedCrossRef
65.
Lanzarini E, Csendes A, Lembach H, et al. Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: retrospective study. World J Surg. 2010;34(9):2098–102. Epub 2010/06/10.PubMedCrossRef
66.
Navarrete SA, Leyba JL, Llopis SN. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results. Obes Surg. 2011;21(5):663–7. Epub 2011/02/22.PubMedCrossRef
67.
Proczko-Markuszewska M, Stefaniak T, Kaska L, et al. Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2. Pol Przegl Chir. 2011;83(2):81–6. Epub 2011/12/15.PubMed
68.
Serrot FJ, Dorman RB, Miller CJ, et al. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2. Surgery. 2011;150(4):684–91. Epub 2011/10/18.PubMedCrossRef
69.
Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2010;6(4):332–8. Epub 2009/10/23.CrossRef
70.
Zhu L, Yang X, Liu S, et al. Effect of laparoscopic Roux-en-Y gastroenterostomy with BMI<35 kg/m2 in type 2 diabetes mellitus. Obes Surg. 2012;22:1562–7.PubMedCrossRef
71.
Garcia-Caballero M, Valle M, Martinez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24–29 BMI patients with one anastomosis gastric bypass. Nutr Hosp: Org Off Soc Esp Nutr Parente Enter. 2012;27(2):623–31. Epub 2012/06/27.
72.
Lee WJ, Chong K, Chen CY, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Obes Surg. 2011;21(7):889–95. Epub 2011/04/19.PubMedCrossRef
73.
Kim Z, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. W J Surg. 2011;35(3):631–6. Epub 2010/12/18.CrossRef
74.
Chiellini C, Rubino F, Castagneto M, et al. The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2. Diabetologia. 2009;52(6):1027–30. Epub 2009/03/25.PubMedCrossRef
75.
Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg. 2011;21(7):880–8. Epub 2011/05/05.PubMedCrossRef
76.
Noya G, Cossu ML, Coppola M, et al. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases. Obes Surg. 1998;8(1):67–72. Epub 1998/04/30.PubMedCrossRef
Metadata
Title
Efficacy of Metabolic Surgery on HbA1c Decrease in Type 2 Diabetes Mellitus Patients with BMI <35 kg/m2—a Review
Authors
Kee Yuan Ngiam
Wei-Jei Lee
Yi-Chih Lee
Anton Cheng
Publication date
01-01-2014
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2014
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-013-1112-y

Other articles of this Issue 1/2014

Obesity Surgery 1/2014 Go to the issue

Original Contributions

Single-Incision Laparoscopic Cholecystectomy and Overweight Patients

Letter to the Editor

Correspondence: Response to Letter to the Editor by K Scharf and J Morton

Brief Communication

Shortening of the QT Interval is Observed Soon after Sleeve Gastrectomy in Morbidly Obese Patients

Original Contributions

Iron Deficiency After Roux-en-Y Gastric Bypass: Insufficient Iron Absorption from Oral Iron Supplements

Other

Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery

Letter to the Editor

Side-to-Side Jejunoileal Anastomosis plus Proximal Loop Ligation: a Novel Intestinal Bypass Model for Diabetic Rats